← Eichor
Study identifier: NCT06795087 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Discharge Medication Use Post-Operatively in GU Cancer Patients

Condition: Genitourinary Cancer  ·  Sponsor: Wake Forest University Health Sciences

PhaseN/A
Planned participants684
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

This description comes directly from the study's public registry record.

Talk to the study team

Margarita Dzhanumova  ·  704-355-2000  ·  Margarita.Dzhanumova@advocatehealth.org

Always discuss trial participation with your own doctor first.

Locations (1)

Levine Cancer InstituteCharlotte, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06795087